NIAID Funding

The National Institute of Allergy and Infectious Diseases (NIAID) provides funding opportunities aimed at supporting research related to infectious, immunologic, and allergic diseases. These opportunities are typically available through grants, contracts, and cooperative agreements, which support a wide range of research activities, from basic research to clinical trials.

NIAID encourages participation from a diverse range of entities, including educational institutions, nonprofit organizations, and businesses of all sizes, particularly those with innovative solutions that can help advance our understanding and treatment of these diseases.

EverGlade's solutions include:

Download the Guide to NIAID Funding

NIAID Funding Programs

A Closer Look at the NIH and DoW Medical Countermeasure Agreement

NIAID Renews IMPAc‑TB to Accelerate Tuberculosis Vaccine Development

Advancing Global Laboratory Quality Through NIAID’s pSMILE Program

Development of Radiation/Nuclear Medical Countermeasures And Biodosimetry Devices

Omnibus Solicitation Seeks Medical Countermeasures for Biodefense and Emerging Infectious Disease

NIAID Omnibus Broad Agency Announcement (BAA)

New NIH Funding Opportunity – Investigating the Role of Genomic Variation on Gene Regulation and Disease

A Guide to NIAID Funding

Why EverGlade?

Federal funding is our science. We create, support, and manage strategic partnerships between innovators and funding agencies to maximize the impact of investment dollars while accelerating our clients’ growth.

Proven in Highly Regulated Federal Environments

With over 50 programs actively managed, we bring hands-on experience across federal agencies in a number of industries, navigating the strategic, technical, and regulatory demands that define successful programs.

Technical & Regulatory Fluency That Drives Post-Award Success

We are PhD-level scientists, former U.S. Government COTRs and SETAs, and federal procurement, financial, cost accounting & compliance regulatory experts who bring diverse perspectives to every stage of the funding lifecycle.

Successful Transition from Program Design to Execution

We operate as an extension of your team — like a “think tank” — where the diverse skill sets of our experts help ensure your program is built to perform from day one.

Powered by Proprietary Program Infrastructure

Your team gains access to proprietary intellectual property developed across years of complex R&D and financial program execution, including standardized tools, templates, and processes.

Ready to Pursue NIAID Funding?

Have a question or ready to discuss your project? Our team can help determine eligibility, align your proposal with agency priorities, and guide you through every step of the process.

NIAID Funding FAQ

What is NIAID and what does it fund?

The National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, funds research on infectious, immunologic, and allergic diseases, spanning basic research through clinical trials in vaccines, therapeutics, and diagnostics. Funding mechanisms include grants, contracts, and cooperative agreements. EverGlade helps researchers and companies build competitive NIAID funding strategies.

What's the difference between NIAID and BARDA?

NIAID primarily funds research and development related to infectious and immune-mediated diseases, while BARDA focuses on advanced development and commercialization of medical countermeasures. Organizations developing health technologies often pursue both agencies at different stages. EverGlade helps companies map their technology to the right agency and funding stage.